In graduate school or after, many of us become statistical Hamlets, asking, “to get a PhD or not to get a PhD?” Unable to pull off an acceptable crossover trial, the ASA Committee on Applied Statisticians gives you the experiences of four statisticians who took different paths after their master’s degrees.
masters notebook
Making Decisions for a Long, Satisfying Career
Susan Duke uses her career as an example of finding your way to a job that gives you internal meaning and purpose.
Musings of a Baby Boomer Data Science Learner
In this month’s column, Bill Bentley writes about why he put his successful consulting practice on simmer to go back to college.
The World of Biostatistics Is a ‘Wild West’: Take Advantage
The pharmaceutical industry is as complicated as it is interesting, and it’s plenty interesting. Jonathan L. Moscovici shares a few of of his experiences as a biopharmaceutical statistician that he didn’t really know (but wishes he did) as a grad student.
From ‘You Can’t’ to ‘I Did’: Master’s-Level Statistician Puts Experience to Work for Others
Statistician Marie Oldfield says she was always bad at math. But then she asked herself, “Why take an easy degree when I can challenge myself?” Here she writes about working to help others who want to go into math and statistics overcome the obstacles they might find in their way.
Lessons from 34 Years as a Master’s Statistician in Industry
Nestor Rohowsky reflects on the lessons of his 34 years in statistics and the key decisions that shaped his career.
Statisticians in Sierra Leone
Dana Haberling and Jodi Vanden Eng both spent some time working as statisticians in Sierra Leone. Here, they share their experiences.
Management Tips from Reyna—My Cleaning Lady
Statistician Mark Otto learns a tip or two about organization and management from his cleaning lady, Renya.
You Are the Master of Your Master’s
Natalie Cheung Hall discusses the benefits of having a master’s degree.
Increasing the Visibility of the Statistics Profession
Sharon Murray of GlaxoSmithKline, Amarjot Kaur of Merck Research Laboratories, and Jennifer Gauvin of GlaxoSmithKline share some of the ideas for increasing visibility that arose during a panel discussion organized by the members of the Committee on Applied Statisticians.